FB2024_04 , released June 25, 2024
Human Disease Model Report: autism spectrum disorder, susceptibility to, X-linked 1
Open Close
General Information
Name
autism spectrum disorder, susceptibility to, X-linked 1
FlyBase ID
FBhh0000521
Overview

This report describes autism spectrum disorder, susceptibility to, X-linked 1 (AUTSX1), one of several forms of autism for which a neuroligin gene is implicated, in this case NLGN3. For additional information about fly models of autism related to neuroligin, see 'autism spectrum disorder, susceptibility to, NLGN-related' (FBhh0000517).

Experiments in flies include characterization of a mutation in a fly neuroligin gene analogous to an NLGN3 variant associated with autism in human. Variant(s) implicated in human disease tested (as analogous mutation in fly gene): R598C in the fly Nlg2 gene (corresponds to R471C in the human NLGN3 gene; also described as R451C).

[updated May 2022 by FlyBase; FBrf0222196]

Disease Summary Information
Parent Disease Summary: autism spectrum disorder, susceptibility to
Symptoms and phenotype

Autism, the prototypic pervasive developmental disorder (PDD), is usually apparent by 3 years of age. It is characterized by a triad of limited or absent verbal communication, a lack of reciprocal social interaction or responsiveness, and restricted, stereotypic, and ritualized patterns of interests and behavior (Bailey et al., 1996, pubmed:8655659; Risch et al., 1999, pubmed:10417292). 'Autism spectrum disorder,' sometimes referred to as ASD, is a broader phenotype encompassing the less severe disorders Asperger syndrome (MIM:608638) and pervasive developmental disorder, not otherwise specified (PDD-NOS). 'Broad autism phenotype' includes individuals with some symptoms of autism, but who do not meet the full criteria for autism or other disorders. Mental retardation coexists in approximately two-thirds of individuals with ASD, except for Asperger syndrome, in which mental retardation is conspicuously absent (Jones et al., 2008; pubmed:18698615). [from MIM:209850; 2017.03.18]

Specific Disease Summary: autism spectrum disorder, susceptibility to, X-linked 1
OMIM report

[AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1](https://omim.org/entry/300425)

Human gene(s) implicated

[NEUROLIGIN 3; NLGN3](https://omim.org/entry/300336)

Symptoms and phenotype
Genetics

X-linked autism-1 (AUTSX1) is associated with mutation in the neuroligin-3 (NLGN3) gene. [from MIM:300425; 2017.03.18]

Cellular phenotype and pathology
Molecular information

Neuroligins function as ligands for the neurexins, which are cell-surface receptors. The Ca(2+)-dependent neurexin/neuroligin complex is present at synapses in the central nervous system, is required for efficient neurotransmission, and is involved in the formation of synaptic contacts (summary by Reissner et al., 2008; pubmed:18812509). [from MIM:600568; 2017.03.18]

External links
Disease synonyms
AUTSX1
X-linked autism-1
Ortholog Information
Human gene(s) in FlyBase
    Human gene (HGNC)
    Symbol / Name
    D. melanogaster ortholog (based on DIOPT)
    Comments on ortholog(s)

    Many to many; multiple genes in both species. In humans, NLGN3 and NLGN4X have been implicated in autism spectrum disorder.

    Other mammalian ortholog(s) used
      D. melanogaster Gene Information (1)
      Gene Snapshot
      Neuroligin 2 (Nlg2) encodes a transmembrane protein that interacts with the product of Nrx-1, and recruits scaffolding proteins for organization of postsynaptic neurotransmitter receptors. The product of Nlg2 functions in synaptic growth and regulation, and is involved in the modulation of social and courtship behavior. [Date last reviewed: 2019-03-14]
      Gene Groups / Pathways
      Comments on ortholog(s)

      Moderate-scoring ortholog of human NLGN1, NLGN3 and NLGN4X (multiple genes in both species).

      Orthologs and Alignments from DRSC
      DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
      Other Genes Used: Viral, Bacterial, Synthetic (0)
        Summary of Physical Interactions (6 groups)
        protein-protein
        Interacting group
        Assay
        References
        anti bait coimmunoprecipitation, western blot
        anti bait coimmunoprecipitation, western blot
        anti tag coimmunoprecipitation, western blot, Identification by mass spectrometry, pull down
        anti tag coimmunoprecipitation, Identification by mass spectrometry, western blot, pull down
        RNA-RNA
        Interacting group
        Assay
        References
        luminiscence technology, necessary binding region
        RNA-protein
        Interacting group
        Assay
        References
        Alleles Reported to Model Human Disease (Disease Ontology) (2 alleles)
        Models Based on Experimental Evidence ( 2 )
        Modifiers Based on Experimental Evidence ( 1 )
        Allele
        Disease
        Interaction
        References
        Alleles Representing Disease-Implicated Variants
        Genetic Tools, Stocks and Reagents
        Sources of Stocks
        Contact lab of origin for a reagent not available from a public stock center.
        Bloomington Stock Center Disease Page
        Related mammalian, viral, bacterial, or synthetic transgenes
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila transgenes
        Allele
        Transgene
        Publicly Available Stocks
        RNAi constructs available
        Allele
        Transgene
        Publicly Available Stocks
        Selected Drosophila classical alleles
        Allele
        Allele class
        Mutagen
        Publicly Available Stocks
        ends-out gene targeting
        ends-out gene targeting
        amorphic allele - molecular evidence
        FLPase
        References (4)